Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin

Infection and Immunity

Volumn 71, Issue 4, 2003, Pages 1813-1819

  Jounblat, Rania ^a   Kadioglu, Aras ^a   Mitchell, Tim J ^b   Andrew, Peter W ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; PNEUMOLYSIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BRONCHOPNEUMONIA; COMPLEMENT ACTIVATION; CYTOLYSIS; CYTOTOXICITY; FEMALE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

ANIMALS; BACTEREMIA; BACTERIAL PROTEINS; BRONCHOPNEUMONIA; COMPLEMENT ACTIVATION; CYTOTOXINS; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG; MICE; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 0037378079     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.4.1813-1819.2003     Document Type: Article

References (19)

1. Alcantra, R. B., L. Preheim, and M. J. Gentry. 1999. Role of pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats. Infect. Immun. 67:2862-2866.
2. Alexander, J. E., A. M. Berry, J. C. Paton, J. B. Rubins, P. W. Andrew, and T. J. Mitchell. 1998. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Microb. Pathog. 24:167-174.
3. Baba, H., I. Kawamura, C. Kohda, T. Nomura, Y. Ito, T. Kimoto, I. Watanabe, S. Ichiyama, and M. Mitsuyama. 2002. Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infect. Immun. 70:107-113.
4. Benton, K. A., J. C. Paton, and D. E. Briles. 1997. The hemolytic and complement activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model. Microb. Pathog. 23:201-209.
5. Berry, A. M., J. E. Alexander, T. J. Mitchell, P. W. Andrew, D. Hansman, and J. C. Paton. 1995. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect. Immun. 63:1969-1974.
6. Boulnois, G. J., J. C. Paton, T. J. Mitchell, and P. W. Andrew. 1991. Structure and function of pneumolysin, the multifunctional thiol-activated toxin of Streptococcus pneumoniae. Mol. Microbiol. 5:2611-2616.
7. Canvin, J. R., A. P. Marvin, M. Sivakumaran, J. C. Paton, G. J. Boulnois, P. W. Andrew, and T. J. Mitchell. 1995. The role of pneumolysin and autolysin in the pathology of pneumonia and septicaemia in mice infected with a type 2 pneumococcus. J. Infect. Dis. 172:119-123.
8. Feldman, C., R. Reed, A. Rutman, N. C. Munro, D. K. Jeffrey, A. Brainy, P. J. Cole, and R. Wilson. 1991. The effect of Streptococcus pneumoniae on intact respiratory epithelium. Eur. Respir. J. 5:576-583.
9. Ferrante, A., B. Rowan Kelly, and J. C. Paton. 1984. Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Infect. Immun. 46:585-589.
10. Houldsworth, S., P. W. Andrew, and T. J. Mitchell. 1994. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect. Immun. 62:1501-1503.
11. Kadioglu, A., and P. Sheldon. 1998. Steroid pulse therapy for rheumatoid arthritis: effect on lymphocytes subsets and mononuclear adhesion. Br. J. Rheumatol. 37:282-286.
12. Kadioglu, A., N. A. Gingles, K. Grattan, A. Kerr, T. J. Mitchell, and P. W. Andrew. 2000. Host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 68:492-501.
13. Kerr, A. R., J. J. Irvine, J. J. Search, N. A. Gingles, A. Kadioglu, P. W. Andrew, W. L. McPheat, C. G. Booth, and T. J. Mitchell. 2002. Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect. Immun. 70:1547-1557.
14. Mitchell, T. J., P. W. Andrew, F. K. Saunders, A. N. Smith, and G. J. Boulnois. 1991. Complement activation and antibody binding by pneumolysin via a region homologous to a human acute phase protein. Mol. Microbiol. 5:1883-1888.
15. Paton, J. C., and A. Ferrante. 1983. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect. Immun. 41:1212-1216.
16. Paton, J. C., B. Rowan Kelly, and A. Ferrante. 1984. Activation of human complement by the pneumococcal toxin pneumolysin. Infect. Immun. 43:1085-1087.
17. Paton, J. C., P. W. Andrew, G. J. Boulnois, and T. J. Mitchell. 1993. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal protein. Annu. Rev. Microbiol 47:89-115.
18. Rubins, J. B., D. Charboneau, J. C. Paton, T. J. Mitchell, P. W. Andrew, and E. N. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Investig. 95:142-150.
19. Rubins, J. B., D. Charboneau, C. Fasching, A. M. Berry, J. C. Paton, J. E. Alexander, P. W. Andrew, T. J. Mitchell, and E. N. Janoff. 1996. Distinct role of pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumoniae. Am. J. Respir. Crit. Care Med. 153:1339-1346.